TRPV1 antagonists (Shenyang Pharmaceutical University/Seoul National University/Ewha Woman's University/National Cancer Institute/Grunenthal)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug NameTRPV1 antagonists (Shenyang Pharmaceutical University/Seoul National University/Ewha Woman's University/National Cancer Institute/Grunenthal)

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionVanilloid receptor antagonists

TargetsTransient receptor potential cation channel subfamily V member 1

Therapy Area/IndicationsPainInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited StatesGermanySouth Korea +[4]

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaPending

Originator CompaniesShenyang Pharmaceutical University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGrunenthal Gmbh National Cancer Institute Ewha Woman'S University +[5]

Active IndicationsN/A

Inactive IndicationsPainInflammation

Other Information

ATC CodeN/A